C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2006
12/26/2006	US7153512 Bovine immunodeficiency virus (BIV) based vectors
12/26/2006	US7153507 A human monoclonal antibody specifically binds to human IL-15 and to inhibit IL-15-induced proinflammatory effects; tumor necrosis factor; antiinflammatory, -arthritic, -carcinogenic, proliferative agents; rheumatic diseases; transplants
12/26/2006	US7153501 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
12/26/2006	US7153500 In vitro culture of human mesenchymal stem cells with CD34+ cells to induce the CD34+ cells to differentiate into megakaryocytic precursors of platelets; gene therapy; genetic and blood disorders; immunotherapy
12/21/2006	WO2006135899A2 Survival, differentiation and structural intergration of human neural stem cells grafted into the adult spinal cord
12/21/2006	WO2006135824A1 Compounds that maintain pluripotency of embryonic stem cells
12/21/2006	WO2006135454A1 Novel cancer cell lines and uses thereof
12/21/2006	WO2006135385A2 Antagonizing interleukin-21 receptor activity
12/21/2006	WO2006135103A1 Method of constructing cartilage tissue by using cell scaffold material in simulated microgravity culture
12/21/2006	WO2006135069A1 Osteoclast differentiation/formation inhibitor, and screening method for prophylactic or therapeutic agent for metabolic bone disorder
12/21/2006	WO2006134951A1 Long-term culture proliferation method for fat-derived stem cell
12/21/2006	WO2006134921A1 Grafting material and agent for improvement in bone quality
12/21/2006	WO2006134917A1 Method for production of antibody
12/21/2006	WO2006134871A1 Method for transfer of gene into fat cell or progenitor fat cell
12/21/2006	WO2006134602A2 Isolated cells and populations comprising same for the treatment of cns diseases
12/21/2006	WO2006134368A1 Idiotype vaccination with bispecific and multispecific immunoglobulin molecules
12/21/2006	WO2006134017A2 Modulation of cells
12/21/2006	WO2006133560A1 Psp94 diagnostic reagents and assays
12/21/2006	WO2006110806A3 Multipotent adult stem cells
12/21/2006	WO2006103685A3 A method for cultivating cells derived from corneal limbal tissue and cells deived from corneal limbal tissue
12/21/2006	WO2006091773A3 Compositions and methods related to serpin spi6
12/21/2006	WO2006086746A8 Homogeneous neural precursor cells
12/21/2006	WO2006083887A3 Production of packaged dna sequences
12/21/2006	WO2006071773A3 Treatment of osteochondral diseases using postpartum-derived cells and products thereof
12/21/2006	WO2006041897A3 Chimeric vectors
12/21/2006	WO2006014999A3 Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating disease
12/21/2006	WO2005116073A3 Pdx1 expressing endoderm
12/21/2006	WO2005099449A3 Animal model, cells, and treatment for malignant melanoma
12/21/2006	WO2004101750A3 IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
12/21/2006	WO2004078922A3 Modulation of growth hormone receptor expression and insulin-like growth factor expression
12/21/2006	WO2004069184A3 Methods for treating, preventing and detecting helicobacter infection
12/21/2006	WO2004020578A3 Glycosylation modified il-20
12/21/2006	WO2003091409A3 Identification of compounds which stimulate bone formation using a cell-based screening assay targeting bmp signaling
12/21/2006	WO2002087306A3 High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds
12/21/2006	US20060288456 Technique for extending biological sugar chain via introduction of glycosyltransferase gene
12/21/2006	US20060288455 modifying plant gene expression and/or by modifying plant haemoglobin levels in a plant; genetic engineering; altering tolerance in plants to various environmental stresses and to increasing seed yield
12/21/2006	US20060288454 Plants having modified growth characteristics and method for making the same
12/21/2006	US20060288453 Nucleotide sequences coding polypeptide for use in enhancing digestibility of plants, improving gum extractability from plants, and altering plant propagation
12/21/2006	US20060288451 Elevation of oil in monocot plants
12/21/2006	US20060288450 Plant N-acylethanolamine binding proteins
12/21/2006	US20060288448 nucleotide sequence encoding Bacillus thuringiensis Cry8Bb1 protoxin, has at least one proteolytic activation site that has been engineered to comprise a cleavage site that is sensitive to an insect gut cysteine protease; transgenic seed and plant
12/21/2006	US20060288446 cell comprising an endochitinase, a stilbene synthase and a superoxide dismutase; encoded from a nucleic acid construct which comprises an internal ribosome entry site sequence; confer resistance to sigatoka
12/21/2006	US20060288445 P15 hairpin constructs and use
12/21/2006	US20060288444 Soybean polymorphisms and methods of genotyping
12/21/2006	US20060288443 Glutamine-rich maize seed protein and promoter
12/21/2006	US20060288442 Use of mixed duplex oligonucleotides to effect localized genetic changes in plants
12/21/2006	US20060288441 nucleotide sequence or complements that code polypeptides having synthetase enzyme activity, used to alter enzyme levels in transformed host cells
12/21/2006	US20060288440 Nucleotide sequences mediating male fertility and method of using same
12/21/2006	US20060288439 Leaf-specific chlorophyll A/B binding protein promoter
12/21/2006	US20060288437 Zinc finger-based drug-dependent gene regulation system
12/21/2006	US20060288434 Inhibiting angiogenesis in a mammal by administering an antibody which specifically binds to EphriniB2 or EphB4; cardiovascular disorders
12/21/2006	US20060288433 Selecting a domestic animal for having desired genotypic properties bytesting the animal for the presence of a parentally imprinted quantitative trait locus; particularly selecting properties related to muscle mass, fat deposition, sow prolificacy, and/or sow longevity in pigs
12/21/2006	US20060288431 Marker for undifferentiated state of cell and composition and method for separation and preparation of stem cells
12/21/2006	US20060287513 Compositions and methods for the therapy and diagnosis of breast cancer
12/21/2006	US20060287503 Analyzing fusion protein expression; biological screening
12/21/2006	US20060287502 C3b/C4b complement receptor-like molecules and uses thereof
12/21/2006	US20060287432 Peptide purification by means of metal ion affinity chromatography
12/21/2006	US20060287281 Phosphohalohydrins, process for the production thereof and use thereof
12/21/2006	US20060287274 Phosphoepoxides, method for making same and uses
12/21/2006	US20060287268 Splice-region antisense composition and method
12/21/2006	US20060287230 Compositions which can be used for regulating the activity of parkin
12/21/2006	US20060287228 Expression of active human factor IX in mammary tissue of transgenic animals
12/21/2006	US20060286670 Transplant acceptance inducing cells of monocytic origin and their preparation and use
12/21/2006	US20060286669 manipulating multi-lineage stem cells, progenitor cells, other marrow stromal cells: allowing the sample of cells to settle in a container; transferring supernatant from the container to another container; and isolating cells from the supernatant, which has comparatively lower density in the sample
12/21/2006	US20060286668 Animal-cell culture media comprising non-animal or plant-derived nutrients
12/21/2006	US20060286667 Mixture of biological cells, used for detection and medical diagnosis of viruses; microbiology; Detecting and differentiating viruses or intracellular parasites present in a specimen; inoculating culture with pathogen and observing for its presence
12/21/2006	US20060286666 Methods and apparatuses for culturing stem cell using biomaterial shell
12/21/2006	US20060286664 Bioreactor for the Manufacture of Tissue Engineered Blood Vessels
12/21/2006	US20060286656 Characterization of the I-SpomI endonuclease from fission yeast
12/21/2006	US20060286642 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
12/21/2006	US20060286638 Cell lines
12/21/2006	US20060286634 Vector
12/21/2006	US20060286633 Methods for production of proteins
12/21/2006	US20060286610 Identification of ligands by selective amplification of cells transfected with receptors
12/21/2006	US20060286592 Increased ability to convert 5-fluorocytosine prodrug to its toxic form
12/21/2006	US20060286591 Methods and compositions for expressing negative-sense viral RNA in canine cells
12/21/2006	US20060286584 Compositions and methods for the regulation of cell proliferation and apoptosis
12/21/2006	US20060286544 Establishment of a human embryonic stem cell line using mammalian cells
12/21/2006	US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis
12/21/2006	US20060286115 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule
12/21/2006	US20060286114 Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
12/21/2006	US20060286112 Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
12/21/2006	US20060286085 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
12/21/2006	US20060286081 Conditioning a culture medium with c-Met Transgenic Murine Hepatocytes and separating the the cells from the medium; adding mammalian cells to the conditioned culture medium; and culturing to grow, expand, and/or maintain the cells; bone marrow cells, stem cells, skin cells, natural killer cells, etc.
12/21/2006	US20060286079 Use of cytokines and mitogens to inhibit pathological immune responses
12/21/2006	US20060286077 Perivascular mesenchymal precursor cell induced blood vessel formation
12/21/2006	US20060286070 for extending clinical utility of interferon (IFN) alpha in treatment of a variety of viral and proliferative disorders; increase efficacy of IFN- alpha and reduce IFN- alpha treatment-related side effects
12/21/2006	US20060286067 Methods for making and using regulatory T cells
12/21/2006	US20060286031 Modulators of tissue regeneration
12/21/2006	DE102004049757B4 Verfahren zur Herstellung eines offenporigen Substrats zur Kultivierung von Gewebezellen A process for preparing an open-cell substrate for the cultivation of tissue cells
12/21/2006	CA2612168A1 Methods for producing antibodies
12/21/2006	CA2611048A1 Psp94 diagnostic reagents and assays
12/21/2006	CA2610598A1 Compounds that maintain pluripotency of embryonic stem cells
12/21/2006	CA2574848A1 Antagonizing interleukin-21 receptor activity
12/20/2006	EP1734126A2 Regeneration
12/20/2006	EP1734123A1 Genetically engineered modification of potato to form amylopectin-type starch
12/20/2006	EP1734122A2 APO-2 ligand
12/20/2006	EP1734120A2 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
12/20/2006	EP1734117A1 Novel fluorescent protein and gene encoding the same
12/20/2006	EP1734113A1 Method for obtaining a skin equivalent

1 ... 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 ... 1827